Aedifica Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 4/3/2026)
| Balance Sheet | Total Assets | 6,477,120,000.00 | ROE | 56.56 % |
| Balance Sheet | Total Equity | 3,663,700,000.00 | ROA | 3.77 % |
| Cashflow | Capital Expenditures | -342,000.00 | P/FCF | 11.26 |
| Cashflow | Free Cash Flow | 262,184,992.00 | – | – |
| Cashflow | Operating Cash Flow | 262,527,000.00 | P/CF | 11.25 |
| Income | Earnings per Share (diluted) | 5.14 | Div. Yield | 6.44 % |
| Income | Net Income | 244,434,000.00 | P/E | 12.08 |
| Income | Shares Outstanding | 47,549,300.00 | P/B | 0.81 |
| Income | Total Revenue | 370,191,000.00 | P/S | 7.98 |
Ratios calculated on: 10/14/2026
Company Description
Aedifica is a Regulated Real Estate Company under Belgian law specialised in European healthcare real estate, particularly in senior housing. Aedifica has developed a portfolio of more than 270 sites in Belgium, Germany, the Netherlands and the United Kingdom, worth more than €2.4 billion. In November, the Group launched a tender offer on the shares of Hoivatilat, the Finnish healthcare real estate investor with which Aedifica wants to enter the Nordics. Aedifica is listed on Euronext Brussels (2006) and Euronext Amsterdam (2019) and is identified by the following ticker symbols: AED; AED:BB (Bloomberg); AOO.BR (Reuters). The Company's market capitalisation was approx. €2.7 billion as of 12 November 2019. Aedifica is included in the EPRA indices.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.aedifica.be
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more